February 19, 2020
ICON Reports Fourth Quarter and Full Year 2019 Results
Highlights Net business wins in the quarter of $930 million; a book to bill of 1.28. Full year net business…
Pharmaceuticals, Biotechnology and Life Sciences
Highlights Net business wins in the quarter of $930 million; a book to bill of 1.28. Full year net business…
Highlights Net business wins in the quarter of $930 million; a book to bill of 1.28. Full year net business…
Highlights Net business wins in the quarter of $930 million; a book to bill of 1.28. Full year net business…
CAMBRIDGE, Mass.–(BUSINESS WIRE)–Cadent Therapeutics, a clinical stage biopharmaceutical company focused on the development of therapies to improve the lives of…
TEL AVIV, Israel–(BUSINESS WIRE)–Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) today announced the Phase 2/3 ARTISTS 1 and Phase…
WALTHAM, Mass.–(BUSINESS WIRE)–Deciphera Pharmaceuticals, Inc. (Nasdaq:DCPH), a clinical-stage biopharmaceutical company focused on addressing key mechanisms of tumor drug resistance, today…
COOKEVILLE, Tenn.–(BUSINESS WIRE)–Aphena Pharma Solutions Inc. has announced the expansion of its bottling capacity with the purchase of a new,…
DUBLIN–(BUSINESS WIRE)–The “Transplant Diagnostics Market – Global Outlook and Forecast 2020-2025” report has been added to ResearchAndMarkets.com’s offering. The global…
DUBLIN–(BUSINESS WIRE)–The “Degenerative Disc Disease – Pipeline Review, H1 2020” drug pipelines has been added to ResearchAndMarkets.com’s offering. Summary The…
DUBLIN–(BUSINESS WIRE)–The “Lyme Disease – Pipeline Review, H1 2020” drug pipelines has been added to ResearchAndMarkets.com’s offering. Summary The latest…